These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33196982)

  • 21. Valvular heart disease in antiphospholipid syndrome.
    Zuily S; Huttin O; Mohamed S; Marie PY; Selton-Suty C; Wahl D
    Curr Rheumatol Rep; 2013 Apr; 15(4):320. PubMed ID: 23456852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and treatment of APS renal involvement.
    Tektonidou MG
    Lupus; 2014 Oct; 23(12):1276-8. PubMed ID: 25228725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiphospholipid syndrome - an update.
    Linnemann B
    Vasa; 2018 Oct; 47(6):451-464. PubMed ID: 30205764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive dysfunction and white matter abnormalities in antiphospholipid syndrome.
    Erkan D; Kozora E; Lockshin MD
    Pathophysiology; 2011 Feb; 18(1):93-102. PubMed ID: 20472406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial Ischaemia, Coronary Atherosclerosis and Pulmonary Pressure Elevation in Antiphospholipid Syndrome Patients.
    Padjas A; Płazak W; Celińska-Lowenhoff M; Mazurek A; Perricone C; Podolec P; Musiał J
    Adv Clin Exp Med; 2016; 25(6):1199-1205. PubMed ID: 28028974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiphospholipid syndrome.
    George D; Erkan D
    Prog Cardiovasc Dis; 2009; 52(2):115-25. PubMed ID: 19732604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silent Myocardial Perfusion Abnormalities Detected by Stress Cardiovascular Magnetic Resonance in Antiphospholipid Syndrome: A Case-Control Study.
    Mavrogeni SI; Markousis-Mavrogenis G; Karapanagiotou O; Toutouzas K; Argyriou P; Velitsista S; Kanoupakis G; Apostolou D; Hautemann D; Sfikakis PP; Tektonidou MG
    J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31340567
    [No Abstract]   [Full Text] [Related]  

  • 29. The antiphospholipid syndrome in patients with systemic lupus erythematosus.
    Pons-Estel GJ; Andreoli L; Scanzi F; Cervera R; Tincani A
    J Autoimmun; 2017 Jan; 76():10-20. PubMed ID: 27776934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiphospholipid Syndrome and the Kidney.
    Sciascia S; Baldovino S; Schreiber K; Solfietti L; Roccatello D
    Semin Nephrol; 2015 Sep; 35(5):478-86. PubMed ID: 26573550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurologic manifestations of antiphospholipid syndrome.
    Ricarte IF; Dutra LA; Abrantes FF; Toso FF; Barsottini OGP; Silva GS; de Souza AWS; Andrade D
    Lupus; 2018 Aug; 27(9):1404-1414. PubMed ID: 29768970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 'Non-Criteria' Neurologic Manifestations of Antiphospholipid Syndrome: A Hidden Kingdom to be Discovered.
    Islam MA; Alam F; Kamal MA; Wong KK; Sasongko TH; Gan SH
    CNS Neurol Disord Drug Targets; 2016; 15(10):1253-1265. PubMed ID: 27658514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes.
    Nalli C; Iodice A; Andreoli L; Lojacono A; Motta M; Fazzi E; Tincani A
    Lupus; 2014 May; 23(6):507-17. PubMed ID: 24763535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Systemic lupus erythematosus and antiphospholipid syndrome - diagnostic and therapeutic problems].
    Zdrojewski Z
    Wiad Lek; 2018; 71(1 pt 1):40-46. PubMed ID: 29558350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stress perfusion Cardiac Magnetic Resonance in Patients with Antiphospholipid Syndrome.
    Tektonidou MG; Sfikakis PP; Kolovou G; Mavrogeni S
    Mediterr J Rheumatol; 2018 Jun; 29(2):99-102. PubMed ID: 32185309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ocular manifestations in antiphospholipid syndrome.
    Suvajac G; Stojanovich L; Milenkovich S
    Autoimmun Rev; 2007 Jun; 6(6):409-14. PubMed ID: 17537387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.